BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9446174)

  • 1. [Therapeutic options in advanced cancer of the prostate].
    Schmid HP; Bitton A
    Praxis (Bern 1994); 1997 Oct; 86(44):1734-9. PubMed ID: 9446174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Possibilities in drug therapy in prostatic carcinoma].
    Schmid HP
    Ther Umsch; 1995 Jun; 52(6):418-22. PubMed ID: 7541571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine treatment of prostate cancer.
    Tammela T
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Conservative therapy of prostate cancer].
    Leitenberger A; Altwein JE
    Fortschr Med; 1991 Sep; 109(28):563-7. PubMed ID: 1721888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hormone therapy of locally advanced and metastatic prostate carcinoma].
    Rübben H
    Praxis (Bern 1994); 2001 Sep; 90(38):1641-4. PubMed ID: 11675917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Management of a hormone dependent cancer with endocrine therapy--prostate cancer].
    Tsukamoto S; Akaza H
    Gan To Kagaku Ryoho; 2001 Jul; 28(7):917-26. PubMed ID: 11478140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment options in androgen-independent prostate cancer.
    Lara PN; Meyers FJ
    Cancer Invest; 1999; 17(2):137-44. PubMed ID: 10071598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical protocols in treatment of prostatic carcinoma in Europe. The role of EORTC and other organizations].
    Newling DW
    Urologe A; 1995 Sep; 34(5):374-81. PubMed ID: 7483153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term results of adjuvant hormonal therapy plus radiotherapy following radical prostatectomy for patients with pT3N0 or pT3N1 prostate cancer.
    Miyake H; Sakai I; Harada K; Hara I; Eto H
    Int J Urol; 2004 Jun; 11(6):397-401. PubMed ID: 15157209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [First line therapy in the treatment of metastatic prostate cancer].
    Sakai H; Kanetake H
    Gan To Kagaku Ryoho; 2003 Jan; 30(1):43-9. PubMed ID: 12557704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Theoretical considerations and initial clinical results of intermittent hormone treatment of patients with advanced prostatic carcinoma].
    Bruchovsky N; Goldenberg SL; Rennie PS; Gleave M
    Urologe A; 1995 Sep; 34(5):389-92. PubMed ID: 7483155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of prostate carcinoma. Age, general health status and stage determine choice of therapy].
    Otto T; Seegenschmiedt MH; Rübben H
    MMW Fortschr Med; 2000 Mar; 142(11):32-4. PubMed ID: 10786086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal therapy for locally advanced prostate cancer.
    Einstein AB
    NCI Monogr; 1988; (7):171-4. PubMed ID: 3050536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen receptor gene amplification at primary progression predicts response to combined androgen blockade as second line therapy for advanced prostate cancer.
    Palmberg C; Koivisto P; Kakkola L; Tammela TL; Kallioniemi OP; Visakorpi T
    J Urol; 2000 Dec; 164(6):1992-5. PubMed ID: 11061898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary hormonal therapy for advanced prostate cancer.
    Lam JS; Leppert JT; Vemulapalli SN; Shvarts O; Belldegrun AS
    J Urol; 2006 Jan; 175(1):27-34. PubMed ID: 16406864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The challenge of locally advanced prostate cancer.
    Pisters LL
    Semin Oncol; 1999 Apr; 26(2):202-16. PubMed ID: 10597731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent complete androgen blockade in metastatic prostate cancer.
    Rambeaud JJ
    Eur Urol; 1999; 35 Suppl 1():32-6. PubMed ID: 10081701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative nonsteroidal antiandrogen therapy for advanced prostate cancer that relapsed after initial maximum androgen blockade.
    Suzuki H; Okihara K; Miyake H; Fujisawa M; Miyoshi S; Matsumoto T; Fujii M; Takihana Y; Usui T; Matsuda T; Ozono S; Kumon H; Ichikawa T; Miki T;
    J Urol; 2008 Sep; 180(3):921-7. PubMed ID: 18635218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy of advanced prostatic carcinoma.
    Millikan RE
    Semin Oncol; 1999 Apr; 26(2):185-91. PubMed ID: 10597729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of advanced prostatic cancer.
    Sogani PC; Fair WR
    Urol Clin North Am; 1987 May; 14(2):353-71. PubMed ID: 2953100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.